Table 1 Summary of clinical experiments.
Participant number | Exp. number | Contrast agent(s) | Dose | Oral/IV | Other products consumed | Sensor position | Relevant figures | Additional Information |
|---|---|---|---|---|---|---|---|---|
1 | i | Fluorescein ICG | 500 mg 25 mg | IV | N/A | Finger Arm Wrist | 2 | – |
2 | i | Fluorescein | 500 mg | IV | N/A | Finger Arm Wrist | – | – |
3 | i | Fluorescein | 500 mg | IV | N/A | Finger Arm Wrist | – | – |
4 | i | Fluorescein | 2.5 g | Oral | 100 ml water | Finger | 3A-C | – |
ii | Fluorescein | 330 mg | Oral | 65 ml water | Finger | S3 | Oral absorption experiment (no dye ingested) | |
iii | Fluorescein | 5 mg, then 25 mg | Oral | 50 ml water (5 mg in 25 ml, then 25 mg in 25 ml) | Arm | 3D | Limit of detection experiment | |
iv | Fluorescein ICG | 500 mg 250 mg | Oral | 130 ml water, 60 g sugar | Arm | S4 S5 | – | |
v | Fluorescein | 500 mg | Oral | 100 ml water | Finger Arm Wrist | 4 | Confocal endo-microscopy experiment | |
vi | Fluorescein | 500 mg | Oral | 1.5 g paracetamol, milkshake (see Table S1) | Finger | 5A | Blood samples collected | |
5 | i | Fluorescein | 500 mg | Oral | 100 ml water | Arm | – | – |
ii | Fluorescein ICG | 500 mg 350 mg | Oral | 140 ml water, 100 g sugar | Arm | S4 S5 | – | |
iii | FITC-Dextran | 1 g | Oral | 100 ml water, 60 g sugar | Finger | 6 S5 | Urine samples collected | |
6 | i | Fluorescein | 500 mg | Oral | 100 ml water | Finger | 5B | – |
ii | Fluorescein | 500 mg | Oral | 100 ml water, 60 g sugar | Finger | 5B | – |
